These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24793142)

  • 1. Deciphering molecular determinants of chemotherapy in gastrointestinal malignancy using systems biology approaches.
    Lin LL; Huang HC; Juan HF;
    Drug Discov Today; 2014 Sep; 19(9):1402-9. PubMed ID: 24793142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods.
    Wong YH; Lin CL; Chen TS; Chen CA; Jiang PS; Lai YH; Chu L; Li CW; Chen JJ; Chen BS
    BMC Med Genomics; 2015; 8 Suppl 4(Suppl 4):S4. PubMed ID: 26680552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems biology of infectious diseases: a focus on fungal infections.
    Santamaría R; Rizzetto L; Bromley M; Zelante T; Lee W; Cavalieri D; Romani L; Miller B; Gut I; Santos M; Pierre P; Bowyer P; Kapushesky M
    Immunobiology; 2011 Nov; 216(11):1212-27. PubMed ID: 21889228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems medicine and metabolic modelling.
    Mardinoglu A; Nielsen J
    J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of chemotherapy on the basis of the results of MTT assay for patients with gastrointestinal cancer].
    Yamaue H; Tanimura H
    Hum Cell; 1995 Dec; 8(4):185-8. PubMed ID: 8721089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational modeling in melanoma for novel drug discovery.
    Pennisi M; Russo G; Di Salvatore V; Candido S; Libra M; Pappalardo F
    Expert Opin Drug Discov; 2016 Jun; 11(6):609-21. PubMed ID: 27046143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends.
    Groessl M; Hartinger CG
    Anal Bioanal Chem; 2013 Feb; 405(6):1791-808. PubMed ID: 23070042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug target identification through systems biology.
    Haanstra JR; Bakker BM
    Drug Discov Today Technol; 2015 Aug; 15():17-22. PubMed ID: 26464086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics and systems biology: application in drug discovery and development.
    Chakravarti B; Mallik B; Chakravarti DN
    Methods Mol Biol; 2010; 662():3-28. PubMed ID: 20824464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems biology of cancer biomarker detection.
    Mitra S; Das S; Chakrabarti J
    Cancer Biomark; 2013; 13(4):201-13. PubMed ID: 24240581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network-Oriented Approaches to Anticancer Drug Response.
    Lecca P; Re A
    Methods Mol Biol; 2017; 1513():101-117. PubMed ID: 27807833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
    Doucet A; Overall CM
    Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases.
    Mei H; Xia T; Feng G; Zhu J; Lin SM; Qiu Y
    Drug Discov Today; 2012 Nov; 17(21-22):1208-16. PubMed ID: 22750722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers.
    Shimoyama S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):729-39. PubMed ID: 21327931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia.
    Zheng PZ; Wang KK; Zhang QY; Huang QH; Du YZ; Zhang QH; Xiao DK; Shen SH; Imbeaud S; Eveno E; Zhao CJ; Chen YL; Fan HY; Waxman S; Auffray C; Jin G; Chen SJ; Chen Z; Zhang J
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7653-8. PubMed ID: 15894607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic chip: next-generation platform for systems biology.
    Feng X; Du W; Luo Q; Liu BF
    Anal Chim Acta; 2009 Sep; 650(1):83-97. PubMed ID: 19720178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Antineoplastic Targets with Systems Approaches, Using Resveratrol as an In-Depth Case Study.
    Singh N; Freiesleben S; Wolkenhauer O; Shukla Y; Gupta SK
    Curr Pharm Des; 2017; 23(32):4773-4793. PubMed ID: 28699531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.
    McIntire M; Redston M
    Arch Pathol Lab Med; 2012 May; 136(5):496-503. PubMed ID: 22229849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the microbiome in drug resistance in gastrointestinal cancers.
    Garajová I; Balsano R; Wang H; Leonardi F; Giovannetti E; Deng D; Peters GJ
    Expert Rev Anticancer Ther; 2021 Feb; 21(2):165-176. PubMed ID: 33115280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.